- Home
- DRUG vs ACB Comparison
DRUG vs ACB Comparison
Compare DRUG & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- ACB
- Stock Information
- Founded
- DRUG 2019
- ACB 2013
- Country
- DRUG United States
- ACB Canada
- Employees
- DRUG N/A
- ACB N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- ACB Pharmaceuticals and Biotechnology
- Sector
- DRUG Health Care
- ACB Health Care
- Exchange
- DRUG Nasdaq
- ACB Nasdaq
- Market Cap
- DRUG 233.2M
- ACB 234.9M
- IPO Year
- DRUG N/A
- ACB N/A
- Fundamental
- Price
- DRUG $32.49
- ACB $4.85
- Analyst Decision
- DRUG Strong Buy
- ACB Hold
- Analyst Count
- DRUG 5
- ACB 1
- Target Price
- DRUG $83.25
- ACB N/A
- AVG Volume (30 Days)
- DRUG 26.6K
- ACB 958.7K
- Earning Date
- DRUG 05-20-2025
- ACB 06-20-2025
- Dividend Yield
- DRUG N/A
- ACB N/A
- EPS Growth
- DRUG N/A
- ACB N/A
- EPS
- DRUG N/A
- ACB 0.07
- Revenue
- DRUG N/A
- ACB $222,964,332.00
- Revenue This Year
- DRUG N/A
- ACB $27.84
- Revenue Next Year
- DRUG N/A
- ACB $11.50
- P/E Ratio
- DRUG N/A
- ACB $73.79
- Revenue Growth
- DRUG N/A
- ACB 20.72
- 52 Week Low
- DRUG $0.93
- ACB $3.42
- 52 Week High
- DRUG $79.02
- ACB $8.14
- Technical
- Relative Strength Index (RSI)
- DRUG 51.29
- ACB 58.95
- Support Level
- DRUG $29.59
- ACB $4.54
- Resistance Level
- DRUG $32.75
- ACB $4.92
- Average True Range (ATR)
- DRUG 2.10
- ACB 0.23
- MACD
- DRUG 0.13
- ACB 0.03
- Stochastic Oscillator
- DRUG 52.35
- ACB 81.20
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About ACB Aurora Cannabis Inc.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.